The origin of the production of diphtheria antitoxin in France, between philanthropy and commerce
- PMID: 18351159
The origin of the production of diphtheria antitoxin in France, between philanthropy and commerce
Abstract
Serotherapy for the treatment of diphtheria represented a major therapeutic innovation at the end of the nineteenth century. The manner in which large-scale production of this medicament was undertaken and the regulations that governed its production and distribution were important elements of public health policy in France as in other European countries. This paper describes the dominance of the Pasteur Institute in this field and, starting from this observation, explores what this event in the history of medicine can tell us about the governance of public health in fin-de-siècle France. The particular organization of this institute and its monopoly of specialist microbiological knowledge allowed it to raise money for serum production from both private and public sources, walking the line between a commercial pharmaceutical venture and a philanthropic enterprise.
Similar articles
-
Diphtheria serum and serotherapy. Development, production and regulation in fin de siècle Germany.Dynamis. 2007;27:107-31. Dynamis. 2007. PMID: 18351161
-
The designing of anti-diphtheria serotherapy at the Institut Pasteur (1888-1900): the role of a supranational network of microbiologists.Dynamis. 2007;27:45-62. Dynamis. 2007. PMID: 18351158
-
The social production of novelty: the diphtheria serotherapy, "herald of the new medicine".Dynamis. 2007;27:21-44. Dynamis. 2007. PMID: 18351157 English, Spanish. No abstract available.
-
History of immunoglobulin replacement.Immunol Allergy Clin North Am. 2008 Nov;28(4):737-64, viii. doi: 10.1016/j.iac.2008.06.004. Immunol Allergy Clin North Am. 2008. PMID: 18940572 Review.
-
[Update on counterfeit drugs: a growing risk for public health].Bull Acad Natl Med. 2008 Oct;192(7):1423-34; discussion 1434-6. Bull Acad Natl Med. 2008. PMID: 19445366 Review. French.
Cited by
-
From Bacterial Poisons to Toxins: The Early Works of Pasteurians.Toxins (Basel). 2022 Nov 3;14(11):759. doi: 10.3390/toxins14110759. Toxins (Basel). 2022. PMID: 36356009 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical